The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
but what I think scientists have all come to terms with is that the technology still needs much more validation and development U before is ready for application uh in this germine editing setting uh the efficiency the specificity both need to be um optimized further
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
So germline is kind of off the table for humans, in part because there is no clearly articulated medical need, and the time for discovering safety and efficacy is over a lifetime which is, you know, unaffordable and ill-advised.